GH Research Plc (GHRS)
20.81
-1.63
(-7.26%)
USD |
NASDAQ |
May 07, 11:57
GH Research Cash from Investing (Quarterly) : 8.566M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | 37.53M |
| Compass Pathways Plc | 0.00 |
| Atai Beckley, Inc. | -40.59M |
| Jazz Pharmaceuticals Plc | 123.10M |
| Nektar Therapeutics | 0.372M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.26M |
| Cash from Financing (Quarterly) | -2.131M |
| Free Cash Flow | -45.04M |
| Free Cash Flow Per Share (Quarterly) | -0.1979 |
| Free Cash Flow to Equity (Quarterly) | -12.20M |
| Free Cash Flow to Firm (Quarterly) | -12.18M |
| Free Cash Flow Yield | -3.55% |